The Alert on Instagram: "Dec 22 - The U.S. Food and Drug Administration has approved Cytokinetics' (CYTK.O), opens new tab oral drug to treat a rare heart condition, the company said on Friday. The keenly watched drug, branded as Myqorzo, was approved for patients with obstructive hypertrophic cardiomyopathy, a condition in which the heart muscle becomes abnormally thick, limiting the heart's pumping and causing symptoms such as shortness of breath, chest pain and dizziness."
0:10
The Alert on Instagram: "Dec 22 - The U.S. Food and Drug Administration has approved Cytokinetics' (CYTK.O), opens new tab oral drug to treat a rare heart condition, the company said on Friday. The keenly watched drug, branded as Myqorzo, was approved for patients with obstructive hypertrophic cardiomyopathy, a condition in which the heart muscle becomes abnormally thick, limiting the heart's pumping and causing symptoms such as shortness of breath, chest pain and dizziness."
22 views5 months ago
Instagramthealert01
See more
Static thumbnail place holder